AVEED offers distinct dosing schedule to increase testosterone levels in hypogonadal men, and underscores Endo's strategy and commitment to addressing health issues facing men To view the multimedia ...

Prostate-specific antigen velocity as a predictive biomarker in a prospective prostate cancer screening study (IMPACT study). This is an ASCO Meeting Abstract from the 2015 Genitourinary Cancers ...

MALVERN, Pa., May 30, 2013 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has ...

18F-fluorocholine positron emission tomography/computed tomography for early outcome prediction in metastatic castration-resistant prostate cancer patients treated with enzalutamide: A ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window BOSTON -- Men ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Three new testosterone therapies offer innovative drug delivery options for men with hypogonadism ...

Please provide your email address to receive an email when new articles are posted on . Testosterone therapy with intramuscular testosterone undecanoate did not result in any adverse cardiovascular or ...

MIAMI -- Oral testosterone replacement therapy (TRT) seemed safe and effective in men with testosterone deficiency, according to a meta-analysis. Among nine studies that looked at changes in serum ...

This article was reviewed by Felix Gussone, MD. How Much Does Testosterone Cost? The Real Deal on Prices and Options Key ...

WASHINGTON--An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with ...